These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 17538094)

  • 1. Coronary microvascular dysfunction.
    Duran JR; Taffet G
    N Engl J Med; 2007 May; 356(22):2324-5; author reply 2325. PubMed ID: 17538094
    [No Abstract]   [Full Text] [Related]  

  • 2. The coronary circulation: plaques, collaterals, and the microcirculation.
    Lüscher TF
    Eur Heart J; 2015 Dec; 36(45):3125-7. PubMed ID: 26628568
    [No Abstract]   [Full Text] [Related]  

  • 3. Coronary microcirculation and cardiovascular pathology.
    Garot P; Teiger E; Dupouy P; Aptecar E; Hittinger L; Dubois-Randé JL
    Drugs; 1999; 59 Spec No():23-31. PubMed ID: 10548389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary microvascular dysfunction and ventricular noncompaction: the chicken or the egg, or both the consequence of a certain undetermined cause?
    Song ZZ
    Cardiol Young; 2008 Oct; 18(5):549-50. PubMed ID: 18706135
    [No Abstract]   [Full Text] [Related]  

  • 5. Left ventricular hypertrophy and coronary microcirculation in hypertensive heart disease.
    Strauer BE; Schwartzkopff B
    Blood Press Suppl; 1997; 2():6-12. PubMed ID: 9495619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary microcirculation and cardiovascular pathology.
    Garot P; Teiger E; Dupouy P; Aptecar E; Hittinger L; Dubois-Randé JL
    Drugs; 1999; 58 Spec No 1():23-31. PubMed ID: 10526955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropeptide Y-induced coronary microvascular dysfunction: a significant contributor to the adverse outcomes in stress cardiomyopathy?
    Yalta K; Sivri N; Yalta T
    Int J Cardiol; 2011 Mar; 147(2):284. PubMed ID: 21145602
    [No Abstract]   [Full Text] [Related]  

  • 8. Microvascular dysfunction in patients with cardiac syndrome X.
    Wu EB
    Heart; 2009 Apr; 95(7):521. PubMed ID: 19164331
    [No Abstract]   [Full Text] [Related]  

  • 9. Position paper of the European Society of Cardiology-working group of coronary pathophysiology and microcirculation: obesity and heart disease.
    Badimon L; Bugiardini R; Cenko E; Cubedo J; Dorobantu M; Duncker DJ; Estruch R; Milicic D; Tousoulis D; Vasiljevic Z; Vilahur G; de Wit C; Koller A
    Eur Heart J; 2017 Jul; 38(25):1951-1958. PubMed ID: 28873951
    [No Abstract]   [Full Text] [Related]  

  • 10. Coronary microvascular dysfunction in primary cardiomyopathies.
    Spoladore R; Fisicaro A; Faccini A; Camici PG
    Heart; 2014 May; 100(10):806-13. PubMed ID: 23904360
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cardiocirculatory system in the advanced age].
    Caccuri S
    Folia Med (Napoli); 1971; 54(8):169-96. PubMed ID: 5152678
    [No Abstract]   [Full Text] [Related]  

  • 12. Coronary vascular resistance and ST-segment changes during coronary microvascular spasm.
    Horimoto M; Kamigaki M; Takenaka T; Inoue H; Igarashi K
    Microvasc Res; 2001 Mar; 61(2):227-9. PubMed ID: 11254404
    [No Abstract]   [Full Text] [Related]  

  • 13. A simple thermodilution technique to assess coronary endothelium-dependent microvascular function in humans: validation and comparison with coronary flow reserve.
    Melikian N; Kearney MT; Thomas MR; De Bruyne B; Shah AM; MacCarthy PA
    Eur Heart J; 2007 Sep; 28(18):2188-94. PubMed ID: 17644509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microvascular obstruction and the no-reflow phenomenon after percutaneous coronary intervention.
    Jaffe R; Charron T; Puley G; Dick A; Strauss BH
    Circulation; 2008 Jun; 117(24):3152-6. PubMed ID: 18559715
    [No Abstract]   [Full Text] [Related]  

  • 15. Importance of improving tissue perfusion during treatment of hypertension.
    Lévy B
    J Hypertens Suppl; 2006 Aug; 24(5):S6-9. PubMed ID: 16936534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein kinase C alpha modulates microvascular reactivity in the human coronary and skeletal microcirculation.
    Sodha NR; Feng J; Clements RT; Bianchi C; Boodhwani M; Ramlawi B; Mieno S; Khabbaz KR; Sellke FW
    Surgery; 2007 Aug; 142(2):243-52. PubMed ID: 17689692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of microvascular flow.
    Kaul S; Jayaweera AR
    Eur Heart J; 2006 Oct; 27(19):2272-4. PubMed ID: 16966343
    [No Abstract]   [Full Text] [Related]  

  • 18. The concept of coronary flow reserve.
    Strauer BE
    J Cardiovasc Pharmacol; 1992; 19 Suppl 5():S67-80. PubMed ID: 1381797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The "slow coronary flow" phenomenon: evidence of preserved coronary flow reserve despite increased resting microvascular resistances.
    Fineschi M; Bravi A; Gori T
    Int J Cardiol; 2008 Jul; 127(3):358-61. PubMed ID: 17651842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How to study coronary microvascular dysfunction and its clinical relevance.
    L'Abbate A; Sambuceti G
    Ital Heart J; 2002 Apr; 3(4):230-6. PubMed ID: 12025371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.